WO1999066324A3 - A bioluminescence resonance energy transfer (bret) system and its use - Google Patents

A bioluminescence resonance energy transfer (bret) system and its use Download PDF

Info

Publication number
WO1999066324A3
WO1999066324A3 PCT/CA1999/000561 CA9900561W WO9966324A3 WO 1999066324 A3 WO1999066324 A3 WO 1999066324A3 CA 9900561 W CA9900561 W CA 9900561W WO 9966324 A3 WO9966324 A3 WO 9966324A3
Authority
WO
WIPO (PCT)
Prior art keywords
bioluminescent protein
fluorophore
protein
bret
energy transfer
Prior art date
Application number
PCT/CA1999/000561
Other languages
French (fr)
Other versions
WO1999066324A2 (en
WO1999066324A9 (en
Inventor
Erik Joly
Carl H Johnson
David W Piston
Original Assignee
Erik Joly
Carl H Johnson
David W Piston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erik Joly, Carl H Johnson, David W Piston filed Critical Erik Joly
Priority to DE69928255T priority Critical patent/DE69928255T2/en
Priority to CA002335305A priority patent/CA2335305C/en
Priority to EP99957096A priority patent/EP1088233B9/en
Priority to AU42542/99A priority patent/AU4254299A/en
Publication of WO1999066324A2 publication Critical patent/WO1999066324A2/en
Publication of WO1999066324A3 publication Critical patent/WO1999066324A3/en
Publication of WO1999066324A9 publication Critical patent/WO1999066324A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/72—Fusion polypeptide containing domain for protein-protein interaction containing SH2 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae

Abstract

This invention provides bioluminescence resonance energy transfer (BRET) system that comprises four parts: 1) a bioluminescent protein that has luciferase activity; 2) an acceptor fluorophore that can accept the energy from the bioluminescent protein when they are associated, in the presence of the appropriate substrate; 3) a modulator that influences the proximity or the orientation of the bioluminescent protein and the fluorophore, and 4) an appropriate substrate to activate the luciferase activity of the bioluminescent protein. The components of this system interact to influence the spatial relationship between the bioluminescent protein and the fluorophore, that is demonstrated by the light emission from the system. The modulator can be a single entity, covalently attached to both the bioluminescent protein and the fluorophore, it can be two separate entities, each linked covalently to either the bioluminescent protein or the fluorophore, or an alternative configuration that falls within the scope of the invention. Thissystem can be used in both in vivo or in vitro assays to detect molecular changes in a wide variety of applications, and is amenable to automation. In particular, it is useful for assaying protein interactions, enzyme activities and the concentration of analytes or signaling molecules in cells or in solution.
PCT/CA1999/000561 1998-06-16 1999-06-16 A bioluminescence resonance energy transfer (bret) system and its use WO1999066324A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE69928255T DE69928255T2 (en) 1998-06-16 1999-06-16 BIOLUMINESCENT RESONANCE ENERGY TRANSFER SYSTEM (BRET) AND ITS APPLICATION
CA002335305A CA2335305C (en) 1998-06-16 1999-06-16 A bioluminescence resonance energy transfer (bret) system and its use
EP99957096A EP1088233B9 (en) 1998-06-16 1999-06-16 A bioluminescence resonance energy transfer (bret) system and its use
AU42542/99A AU4254299A (en) 1998-06-16 1999-06-16 A bioluminescence resonance energy transfer (bret) system and its use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8962398P 1998-06-16 1998-06-16
US60/089,623 1998-06-16

Publications (3)

Publication Number Publication Date
WO1999066324A2 WO1999066324A2 (en) 1999-12-23
WO1999066324A3 true WO1999066324A3 (en) 2000-04-06
WO1999066324A9 WO1999066324A9 (en) 2000-07-13

Family

ID=22218673

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1999/000561 WO1999066324A2 (en) 1998-06-16 1999-06-16 A bioluminescence resonance energy transfer (bret) system and its use

Country Status (5)

Country Link
EP (1) EP1088233B9 (en)
AU (1) AU4254299A (en)
CA (1) CA2335305C (en)
DE (1) DE69928255T2 (en)
WO (1) WO1999066324A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110330558B (en) * 2019-08-05 2020-09-22 博迈德生物科技（固安）有限公司 Yellow fluorescent protein and application thereof

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
CN1160470C (en) * 1998-09-03 2004-08-04 洛马林达大学 Method for studying protein interactions i(invivo)
AU2137101A (en) * 1999-12-22 2001-07-03 Biosignal Packard Inc. A bioluminescence resonance energy transfer (bret) fusion molecule and method ofuse
JP2001327296A (en) * 2000-03-15 2001-11-27 Japan Science & Technology Corp Method for detecting interaction between protein and protein
AU781992B2 (en) * 2000-04-04 2005-06-23 Medical Research Council Methods involving induced dimerisation by cellular components
US7163800B2 (en) 2000-11-03 2007-01-16 Molecular Devices Corporation Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US7018812B2 (en) 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
US20020073441A1 (en) * 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
WO2003004643A2 (en) 2001-07-03 2003-01-16 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Reversed mammalian protein-protein interaction trap
FR2826666B1 (en) * 2001-07-02 2004-07-02 Novaleads METHOD FOR SELECTING BIO-ACTIVE AGENTS BY LUMINESCENCE COUPLING AND LIVING CELLULAR SYSTEM FOR CARRYING OUT SAID METHOD
ATE509120T1 (en) 2001-09-18 2011-05-15 Carnegie Inst Of Washington FUSION PROTEINS FOR DETECTING ANALYTES
US7268229B2 (en) 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
US7846671B2 (en) 2002-01-28 2010-12-07 Bristol-Myers Squibb Company Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence
FR2836475B1 (en) 2002-02-26 2007-02-23 Aventis Pharma Sa METHOD FOR DETECTING LEPTIN RECEPTOR LIGANDS
EP1579212B1 (en) 2002-10-25 2008-12-31 MDS Analytical Technologies (US) Inc. Methods of identifying reduced internalization transmembrane receptor agonists
WO2004052934A1 (en) * 2002-12-12 2004-06-24 National Institute Of Advanced Industrial Science And Technology Monitor protein for measuring processing of protein
AU2003293959A1 (en) 2002-12-20 2004-07-14 Julius-Maximilians-Uni Versitat Wurzburg Millisecond activation switch for seven-transmembrane proteins
US8883486B2 (en) 2004-05-04 2014-11-11 Universite De Montreal Arrestin biosensor
CA2607015C (en) 2004-05-04 2016-07-05 Universite De Montreal Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
EP2400030B1 (en) * 2004-05-18 2016-01-20 The Board of Trustees of the Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
WO2006086883A1 (en) * 2005-02-16 2006-08-24 Universite De Montreal Biosensors for monitoring receptor-mediated g-protein activation
KR20080050584A (en) 2005-08-19 2008-06-09 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 Arachnocampa luciferases
US7910087B2 (en) 2007-03-02 2011-03-22 University Of Massachusetts Luciferins
DE102010018878B4 (en) 2009-04-30 2013-09-26 Julius-Maximilians-Universität Würzburg New cell line for the fluorescence-based detection of functionally active antibodies and autoantibodies against the beta1-adrenergic receptor
US9127282B2 (en) 2011-06-24 2015-09-08 University Of Houston System Fusion proteins of bacterial luciferase as multicolor luminescent sensors
RU2497128C2 (en) * 2011-12-30 2013-10-27 Федеральное Государственное Автономное Образовательное Учреждение Высшего Профессионального Образования "Сибирский Федеральный Университет" Method for simultaneous determination of two analytes via bioluminescent molecular microanalysis
US10067149B2 (en) 2012-12-12 2018-09-04 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
WO2014093677A1 (en) 2012-12-12 2014-06-19 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US20180251765A1 (en) * 2015-09-08 2018-09-06 BellBrook Labs High-throughput split aptamer screening assay
CN107164457B (en) * 2017-04-26 2021-01-26 北京工商大学 High-throughput screening method of broad-spectrum lysozyme
EP3882632A1 (en) * 2020-03-18 2021-09-22 Universite De Bordeaux Novel ion conducting channel fusion subunits and methods of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KOJIMA S ET AL: "Mechanism of the Redox Reaction of the Aequorea Green Fluorescent Protein (GFP)", TETRAHEDRON LETTERS,NL,ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, vol. 38, no. 16, pages 2875-2878, XP004058517, ISSN: 0040-4039 *
WU P ET AL: "RESONANCE ENERGY TRANSFER: METHODS AND APPLICATIONS", ANALYTICAL BIOCHEMISTRY,US,ACADEMIC PRESS, SAN DIEGO, CA, vol. 218, pages 1-13, XP002033685, ISSN: 0003-2697 *
XU, YAO ET AL: "A bioluminescence resonance energy transfer ( BRET ) system: application to interacting circadian clock proteins", PROC. NATL. ACAD. SCI. U. S. A. (1999), 96(1), 151-156, XP002127270 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110330558B (en) * 2019-08-05 2020-09-22 博迈德生物科技（固安）有限公司 Yellow fluorescent protein and application thereof

Also Published As

Publication number Publication date
CA2335305C (en) 2006-05-23
CA2335305A1 (en) 1999-12-23
EP1088233B1 (en) 2005-11-09
DE69928255D1 (en) 2005-12-15
WO1999066324A2 (en) 1999-12-23
EP1088233B9 (en) 2006-05-17
DE69928255T2 (en) 2006-11-09
AU4254299A (en) 2000-01-05
EP1088233A2 (en) 2001-04-04
WO1999066324A9 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
WO1999066324A3 (en) A bioluminescence resonance energy transfer (bret) system and its use
Medintz et al. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot–peptide conjugates
Wei et al. Enzyme colorimetric assay using unmodified silver nanoparticles
Kumaraswamy et al. Fluorescent-conjugated polymer superquenching facilitates highly sensitive detection of proteases
Premkumar et al. Sol–gel luminescence biosensors: Encapsulation of recombinant E. coli reporters in thick silicate films
Malashikhina et al. Unconventional application of conventional enzymatic substrate: first fluorogenic immunoassay based on enzymatic formation of quantum dots
IL125985A0 (en) Graphitic nanotubes in luminescence assays
CY1110515T1 (en) DETERMINATION OF UNION-PROTEIN INTERACTIONS USING LIBRARY PROTEIN-NUCLEAR ACID Fusion Molecules
EP0137515A2 (en) Bioluminescent immunoassays
ATE254186T1 (en) ELECTROCHEMILUMINESCENT ENZYMBIOS SENSORS
GB9902659D0 (en) Assay with reduced background
Yang et al. Poly (thymine)-templated selective formation of copper nanoparticles for alkaline phosphatase analysis aided by alkyne–azide cycloaddition “click” reaction
Miller et al. Characterization of a soluble cytochrome oxidase/nitrite reductase from Nitrosomonas europaea
Kivirand et al. Biosensors for the detection of antibiotic residues in milk
ATE304595T1 (en) LIGHT PRODUCING BIOSENSOR
ES2125986T3 (en) SENSOR FOR OPTICAL TEST.
ATE272721T1 (en) NUCLEIC ACID HYBRIDIZATION TEST PROCEDURE IN SOLUTION
Esimbekova et al. Disk-shaped immobilized multicomponent reagent for bioluminescent analyses: correlation between activity and composition
Smiley et al. Single-molecule investigation of the T4 bacteriophage DNA polymerase holoenzyme: multiple pathways of holoenzyme formation
Sakharov et al. Use of soybean peroxidase in chemiluminescent enzyme-linked immunosorbent assay
Chiu et al. Hybridization assays using an expressible DNA fragment encoding firefly luciferase as a label
ATE259424T1 (en) ENZYME SUBSTRATES AND INTRAMOLECULAR FRET ASSAY
AU2002245206A1 (en) Dendritic chemiluminescent substrates
Basile et al. Simultaneous multiple substrate tag detection with ESI-ion trap MS for in vivo bacterial enzyme activity profiling
Lewis et al. Site-specifically labeled photoprotein-thyroxine conjugates using aequorin mutants containing unique cysteine residues: applications for binding assays (Part II)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1, 2 AND 4-8, DESCRIPTION, REPLACED BY NEW PAGES 1, 2 AND 4-8; AFTER RECTIFICATION OF OBVIOUSERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY

ENP Entry into the national phase

Ref document number: 2335305

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 09719730

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1999957096

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999957096

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1999957096

Country of ref document: EP